Abstract
Steady state serum levels have been found to be useful measurements when selecting dosage for medications. This has worked well with such drugs as digoxin, aminophylline, and phenytoin sodium, but work with neuroleptics has been less successful. A number of problems hamper research in this field. Certain medications show extremely low serum levels; problems occur with enzyme induction and multiple metabolites; and the assays are technically complex. Many studies have used flexible dose schedules which can obscure therapeutic results when additional medication is added to the regimens of nonresponsive patients or doses are reduced because of side effects. Finally, the most difficult obstacle to overcome is obtaining steady state levels in short-term acute care clinical settings where rapid patient turnover and brief hospitalization are the rule.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
S. S. Chang, H. Dekirmenjian, A. Walcynski, et al., Clinical pharmacological studies of antipsychotics. Read before a meeting of the Society of Biological Psychiatry, Atlanta, May, 1978.
J. A. Yesavage, J. Becker, P.D. Werner, et al., Serum level monitoring of thiothixene in schizophrenia: acute single- dose levels at fixed doses, Am. J. Psychiatr. 139:2 (1982).
L. Jacobsson, L. Von Knorring, B. Mattsson, et al., Penfluridol and thiothixene: dosage, plasma level and changes in psychopathology. Int. Pharmacopsychiatry 11:206 (1976).
L. Jacobsson, L. Von Knorring, B. Mattsson, et al., Controlled trial of penfluridol and thiothixene in the maintenance treatment of chronic schizophrenic syndromes, Acta. Psychiatr. Scand. 54:113 (1976).
T. Mjorndal and L. Oreland, Determination of thiothixenes in plasma at therapeutic concentrations, Acta. Pharmacol. Toxicol. (Copenh) 29:295 (1971).
J. A. Yesavage, C. A. Holman, R. Cohn and L. Lombrozo, Correlation of initial thiothixene serum levels and clinical response. Comparison of fluorometric, gas chromatographic, and RBC assays, Arch. Gen. Psychiatr. 40:301 (1983).
S. P. Roose, S. Bone, C. Haidorfer, D. L. Dunne and R. R. Fieve, Lithium treatment in older patients, Am. J. Psychiatr. 136:843 (1979).
R. Braithwaite, S. Montgomery, and S. Dawling, Depression and tricyclic antidepressant levels, in “Drugs and the “Elderly,” J. Crooks and I.H. Stevens, eds., University Park Press, Baltimore (1979).
J. A. Yesavage, Inpatient violence and the schizophrenic patient: an inverse correlation between danger-related events and neuroleptic levels, Biol. Psychiatr. 17 (no. 11):1331 (1982).
D. Student and J. R. Lion, Methodological Issues in Psycho-pharmacological Research in Violent Individuals, International Society for Research on Aggression, National Institutes of Medicine.
J. A. Yesavage, P. D. Werner, J. M. T. Becker, C. A. Holman and M. J. Mills, Inpatient evaluation of aggression in psychiatric patients, J. Nervous Ment. Pis. 169:299 (1981).
J. A. Yesavage, Correlates of dangerous behavior by schizophrenics in hospital (unpublished data, 1983)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yesavage, J.A. (1985). Plasma Levels as Predictors of Clinical Response and Violent Behavior. In: Pichot, P., Berner, P., Wolf, R., Thau, K. (eds) Biological Psychiatry, Higher Nervous Activity. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8329-1_73
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8329-1_73
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8331-4
Online ISBN: 978-1-4684-8329-1
eBook Packages: Springer Book Archive